tiprankstipranks
Cryo-Cell International Inc (CCEL)
:CCEL
US Market
Want to see CCEL full AI Analyst Report?

Cryo-Cell International (CCEL) Ratios

54 Followers

Cryo-Cell International Ratios

CCEL's free cash flow for Q2 2026 was $0.76. For the 2026 fiscal year, CCEL's free cash flow was decreased by $ and operating cash flow was $0.16. See a summary of the company’s cash flow.
Ratios
TTM
Nov 25Feb 25Nov 23Feb 23
Liquidity Ratios
Current Ratio
0.71 0.59 0.58 0.45 0.49
Quick Ratio
0.69 0.57 0.55 0.42 0.45
Cash Ratio
0.03 0.02 0.03 0.02 0.09
Solvency Ratio
-0.02 -0.01 0.01 -0.11 0.07
Operating Cash Flow Ratio
0.40 0.28 0.28 0.43 0.44
Short-Term Operating Cash Flow Coverage
10.24 2.21 1.63 6.42 3.54
Net Current Asset Value
$ -67.16M$ -68.58M$ -65.34M$ -62.80M$ -56.80M
Leverage Ratios
Debt-to-Assets Ratio
0.15 0.19 0.20 0.18 0.18
Debt-to-Equity Ratio
-0.50 -0.62 -0.98 -0.99 -7.62
Debt-to-Capital Ratio
-1.02 -1.64 -45.85 -80.59 1.15
Long-Term Debt-to-Capital Ratio
-0.84 -0.78 -1.69 -3.24 1.22
Financial Leverage Ratio
-3.42 -3.32 -4.89 -5.55 -42.57
Debt Service Coverage Ratio
0.26 0.22 -0.18 -2.50 1.55
Interest Coverage Ratio
-0.05 2.34 1.87 -9.95 2.64
Debt to Market Cap
0.24 0.33 0.17 0.22 0.30
Interest Debt Per Share
1.35 1.69 1.82 1.45 1.55
Net Debt to EBITDA
14.61 10.24 8.70 -1.01 1.49
Profitability Margins
Gross Profit Margin
77.34%76.63%75.15%73.07%71.02%
EBIT Margin
-2.00%-0.86%2.94%-38.69%15.96%
EBITDA Margin
1.86%3.48%4.45%-33.24%21.92%
Operating Profit Margin
-0.33%15.34%10.88%-39.26%13.27%
Pretax Profit Margin
-8.19%-7.40%8.77%-42.64%10.94%
Net Profit Margin
-7.92%-7.70%1.26%-30.38%9.14%
Continuous Operations Profit Margin
-7.92%-7.70%1.26%-30.38%9.14%
Net Income Per EBT
96.80%103.95%14.34%71.25%83.50%
EBT Per EBIT
2455.18%-48.28%80.57%108.62%82.47%
Return on Assets (ROA)
-4.06%-3.94%0.62%-15.55%4.27%
Return on Equity (ROE)
14.18%13.06%-3.04%86.32%-181.81%
Return on Capital Employed (ROCE)
-0.23%11.54%8.08%-30.49%8.86%
Return on Invested Capital (ROIC)
-0.22%10.79%1.06%-20.89%6.98%
Return on Tangible Assets
-4.26%-4.12%0.65%-16.33%5.80%
Earnings Yield
-6.71%-7.56%0.57%-21.34%7.49%
Efficiency Ratios
Receivables Turnover
4.50 4.61 4.38 4.77 5.02
Payables Turnover
2.48 2.57 4.22 2.66 5.48
Inventory Turnover
22.74 18.04 12.08 10.98 10.33
Fixed Asset Turnover
1.46 1.44 1.41 1.42 2.14
Asset Turnover
0.51 0.51 0.49 0.51 0.47
Working Capital Turnover Ratio
-5.50 -3.70 -3.13 -2.95 -4.00
Cash Conversion Cycle
-50.26 -42.66 27.17 -27.43 41.41
Days of Sales Outstanding
81.03 79.16 83.41 76.58 72.72
Days of Inventory Outstanding
16.05 20.23 30.20 33.24 35.34
Days of Payables Outstanding
147.34 142.05 86.44 137.25 66.64
Operating Cycle
97.08 99.39 113.61 109.82 108.06
Cash Flow Ratios
Operating Cash Flow Per Share
0.78 0.68 0.74 1.07 1.01
Free Cash Flow Per Share
0.76 0.65 0.30 0.15 -1.02
CapEx Per Share
0.03 0.03 0.44 0.92 2.03
Free Cash Flow to Operating Cash Flow
0.97 0.96 0.40 0.14 -1.00
Dividend Paid and CapEx Coverage Ratio
30.69 1.58 1.07 1.17 0.35
Capital Expenditure Coverage Ratio
30.69 23.77 1.67 1.17 0.50
Operating Cash Flow Coverage Ratio
0.70 0.47 0.46 0.82 0.74
Operating Cash Flow to Sales Ratio
0.20 0.17 0.19 0.28 0.28
Free Cash Flow Yield
16.62%16.34%3.41%2.87%-23.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-15.50 -13.27 175.31 -4.69 13.35
Price-to-Sales (P/S) Ratio
1.18 1.02 2.20 1.42 1.22
Price-to-Book (P/B) Ratio
-2.07 -1.73 -5.33 -4.05 -24.27
Price-to-Free Cash Flow (P/FCF) Ratio
6.02 6.12 29.28 34.84 -4.30
Price-to-Operating Cash Flow Ratio
5.82 5.86 11.73 5.00 4.32
Price-to-Earnings Growth (PEG) Ratio
0.70 0.02 -1.68 0.01 0.50
Price-to-Fair Value
-2.07 -1.73 -5.33 -4.05 -24.27
Enterprise Value Multiple
78.18 39.51 58.23 -5.29 7.05
Enterprise Value
45.22M 43.35M 82.87M 55.11M 46.90M
EV to EBITDA
78.18 39.51 58.23 -5.29 7.05
EV to Sales
1.45 1.37 2.59 1.76 1.55
EV to Free Cash Flow
7.40 8.26 34.42 43.03 -5.46
EV to Operating Cash Flow
7.16 7.91 13.79 6.18 5.47
Tangible Book Value Per Share
-2.55 -2.65 -1.98 -1.67 -2.20
Shareholders’ Equity Per Share
-2.20 -2.31 -1.63 -1.32 -0.18
Tax and Other Ratios
Effective Tax Rate
0.03 -0.04 0.86 0.29 0.16
Revenue Per Share
3.86 3.91 3.93 3.76 3.58
Net Income Per Share
-0.31 -0.30 0.05 -1.14 0.33
Tax Burden
0.97 1.04 0.14 0.71 0.84
Interest Burden
4.09 8.63 2.98 1.10 0.69
Research & Development to Revenue
0.01 0.01 0.04 0.04 0.01
SG&A to Revenue
0.61 0.58 0.58 0.00 0.00
Stock-Based Compensation to Revenue
<0.01 0.01 0.02 0.03 0.02
Income Quality
-2.56 -2.26 14.95 -0.94 3.09
Currency in USD